

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.63349213 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71807550 |
| 3 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.61731285 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.57834150 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.50124682 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.48377315 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.38436666 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08542787 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08542787 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07564041 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.07564041 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07564041 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07564041 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07564041 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.07564041 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 3.94173617 |
| 17 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86950035 |
| 18 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.84079262 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.72641212 |
| 20 | regulation of B cell differentiation (GO:0045577) | 3.69609095 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.68985627 |
| 22 | respiratory burst (GO:0045730) | 3.63795267 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.62860552 |
| 24 | neutrophil activation (GO:0042119) | 3.59762500 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.58767912 |
| 26 | * B cell receptor signaling pathway (GO:0050853) | 3.54603593 |
| 27 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.53965347 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.53278733 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.51966461 |
| 30 | granulocyte activation (GO:0036230) | 3.45743172 |
| 31 | regulation of B cell apoptotic process (GO:0002902) | 3.42005172 |
| 32 | positive regulation of granulocyte differentiation (GO:0030854) | 3.35688513 |
| 33 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.35457533 |
| 34 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34463251 |
| 35 | megakaryocyte development (GO:0035855) | 3.31838855 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30682968 |
| 37 | regulation of antigen processing and presentation (GO:0002577) | 3.24950266 |
| 38 | myeloid dendritic cell activation (GO:0001773) | 3.24329713 |
| 39 | pinocytosis (GO:0006907) | 3.24110508 |
| 40 | definitive hemopoiesis (GO:0060216) | 3.19197930 |
| 41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16924484 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14420038 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.13755370 |
| 44 | mature B cell differentiation involved in immune response (GO:0002313) | 3.12244249 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.12071281 |
| 46 | natural killer cell mediated immunity (GO:0002228) | 3.07607791 |
| 47 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.07607791 |
| 48 | germinal center formation (GO:0002467) | 3.07306485 |
| 49 | response to peptidoglycan (GO:0032494) | 3.05053435 |
| 50 | cellular response to zinc ion (GO:0071294) | 3.03427473 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.03374106 |
| 52 | myeloid dendritic cell differentiation (GO:0043011) | 3.02632855 |
| 53 | cellular response to exogenous dsRNA (GO:0071360) | 3.02029656 |
| 54 | response to muramyl dipeptide (GO:0032495) | 2.97372153 |
| 55 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.94670217 |
| 56 | positive regulation of interferon-beta production (GO:0032728) | 2.90986239 |
| 57 | leukocyte mediated cytotoxicity (GO:0001909) | 2.89654605 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89581022 |
| 59 | negative regulation of cell killing (GO:0031342) | 2.89581022 |
| 60 | positive thymic T cell selection (GO:0045059) | 2.89334708 |
| 61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.87029202 |
| 62 | B cell mediated immunity (GO:0019724) | 2.87000235 |
| 63 | neutrophil mediated immunity (GO:0002446) | 2.85125192 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85062672 |
| 65 | regulation of germinal center formation (GO:0002634) | 2.84868198 |
| 66 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.84632348 |
| 67 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.82170530 |
| 68 | negative regulation of interleukin-12 production (GO:0032695) | 2.81644971 |
| 69 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.78803245 |
| 70 | cellular extravasation (GO:0045123) | 2.77114121 |
| 71 | positive regulation of B cell activation (GO:0050871) | 2.76570404 |
| 72 | mature B cell differentiation (GO:0002335) | 2.73580130 |
| 73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72782305 |
| 74 | positive regulation of interleukin-12 production (GO:0032735) | 2.72571850 |
| 75 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72012653 |
| 76 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.71490899 |
| 77 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.70794465 |
| 78 | defense response to protozoan (GO:0042832) | 2.70752909 |
| 79 | regulation of granulocyte differentiation (GO:0030852) | 2.70332096 |
| 80 | regulation of T-helper cell differentiation (GO:0045622) | 2.70302407 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69565344 |
| 82 | response to host immune response (GO:0052572) | 2.69565344 |
| 83 | dendritic cell differentiation (GO:0097028) | 2.68464188 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.66737865 |
| 85 | T-helper 1 type immune response (GO:0042088) | 2.65863755 |
| 86 | response to type I interferon (GO:0034340) | 2.64998679 |
| 87 | negative thymic T cell selection (GO:0045060) | 2.64983776 |
| 88 | regulation of B cell proliferation (GO:0030888) | 2.64595702 |
| 89 | myeloid leukocyte activation (GO:0002274) | 2.64130030 |
| 90 | leukocyte aggregation (GO:0070486) | 2.63600207 |
| 91 | dendritic cell chemotaxis (GO:0002407) | 2.63551569 |
| 92 | B cell homeostasis (GO:0001782) | 2.63281109 |
| 93 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.63241223 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 2.63173921 |
| 95 | hepatocyte apoptotic process (GO:0097284) | 2.62006732 |
| 96 | detection of bacterium (GO:0016045) | 2.61629936 |
| 97 | cytokine secretion (GO:0050663) | 2.61240844 |
| 98 | detection of other organism (GO:0098543) | 2.60972197 |
| 99 | regulation of mast cell activation (GO:0033003) | 2.60958482 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60714083 |
| 101 | type I interferon signaling pathway (GO:0060337) | 2.60416205 |
| 102 | cellular response to type I interferon (GO:0071357) | 2.60416205 |
| 103 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.58587783 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58225073 |
| 105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.57339939 |
| 106 | dendritic cell migration (GO:0036336) | 2.57201162 |
| 107 | microglial cell activation (GO:0001774) | 2.56809107 |
| 108 | negative regulation of B cell proliferation (GO:0030889) | 2.56343455 |
| 109 | response to protozoan (GO:0001562) | 2.55577817 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55530930 |
| 111 | histamine secretion (GO:0001821) | 2.54035442 |
| 112 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.53940996 |
| 113 | cytidine metabolic process (GO:0046087) | 2.53917948 |
| 114 | cytidine catabolic process (GO:0006216) | 2.53917948 |
| 115 | cytidine deamination (GO:0009972) | 2.53917948 |
| 116 | leukocyte degranulation (GO:0043299) | 2.53167505 |
| 117 | macrophage activation (GO:0042116) | 2.52515622 |
| 118 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.52464072 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52351094 |
| 120 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.52252385 |
| 121 | Peyers patch development (GO:0048541) | 2.51494340 |
| 122 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.51494340 |
| 123 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51459454 |
| 124 | regulation of B cell activation (GO:0050864) | 2.51438038 |
| 125 | negative regulation of granulocyte differentiation (GO:0030853) | 2.51335652 |
| 126 | positive regulation of interleukin-2 production (GO:0032743) | 2.51268736 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.50547593 |
| 128 | regulation of mast cell degranulation (GO:0043304) | 2.50526074 |
| 129 | mast cell activation (GO:0045576) | 2.49851461 |
| 130 | negative T cell selection (GO:0043383) | 2.49652130 |
| 131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49453253 |
| 132 | response to host (GO:0075136) | 2.49453253 |
| 133 | response to host defenses (GO:0052200) | 2.49453253 |
| 134 | positive regulation of macrophage differentiation (GO:0045651) | 2.48825795 |
| 135 | reactive oxygen species biosynthetic process (GO:1903409) | 2.48650436 |
| 136 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.48028668 |
| 137 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.47493973 |
| 138 | I-kappaB phosphorylation (GO:0007252) | 2.46959941 |
| 139 | T cell migration (GO:0072678) | 2.45940184 |
| 140 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.45892514 |
| 141 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.45480825 |
| 142 | regulation of interferon-beta production (GO:0032648) | 2.45068780 |
| 143 | cellular response to interferon-gamma (GO:0071346) | 2.44137193 |
| 144 | positive regulation of B cell proliferation (GO:0030890) | 2.42960516 |
| 145 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.41579431 |
| 146 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.41449111 |
| 147 | positive regulation of mast cell activation (GO:0033005) | 2.41092757 |
| 148 | cellular response to ethanol (GO:0071361) | 2.40995785 |
| 149 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.39592090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.79797512 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.75987402 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.87640073 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.75651528 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63087597 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.53479970 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.44892263 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37064588 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34372125 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18967921 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.07307299 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90413351 |
| 13 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80268263 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.74210624 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.58283841 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.58154049 |
| 17 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.42627848 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39737530 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27612692 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.26905968 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26559237 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.24773046 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24761818 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24595552 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24315839 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.15641931 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.11002374 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06497308 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04611170 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00830014 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.00113074 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.99398646 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.98323736 |
| 34 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95838193 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95411135 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95073397 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92665856 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.92586580 |
| 39 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92062080 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91982921 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.91315417 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87131540 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.76674828 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73087416 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.70614445 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65874953 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62697981 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61953581 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61195362 |
| 50 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59022163 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.58673751 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56189801 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53646894 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50882117 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48680661 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.44811688 |
| 57 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.44676802 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43782260 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41248013 |
| 60 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37611015 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36841629 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33903911 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33686391 |
| 64 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29765632 |
| 65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28544548 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25851595 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24689802 |
| 68 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.21795356 |
| 69 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.21341583 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21220745 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20856962 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20738279 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19931725 |
| 74 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19762943 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19746960 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18544055 |
| 77 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17999113 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.17616780 |
| 79 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17007748 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15722201 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15337245 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15324507 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13739355 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13001240 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12027247 |
| 86 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.11924415 |
| 87 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09709754 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09402047 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07675020 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04949904 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03249890 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03144411 |
| 93 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.01912636 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.01668101 |
| 95 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01362862 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00748403 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99726681 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98957338 |
| 99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98803007 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98086972 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98070875 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97596379 |
| 103 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97401845 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95717674 |
| 105 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94179214 |
| 106 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92703173 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92605531 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92573467 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92364790 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91357060 |
| 111 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91303062 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90234079 |
| 113 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89754771 |
| 114 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.88965225 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88508374 |
| 116 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.86457306 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85492940 |
| 118 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.84859327 |
| 119 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.84832212 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84292660 |
| 121 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.83956390 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81049605 |
| 123 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.80394088 |
| 124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80199533 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80005920 |
| 126 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.76259261 |
| 127 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73807556 |
| 128 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72430662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.49654666 |
| 2 | MP0003436_decreased_susceptibility_to | 3.03551271 |
| 3 | MP0000685_abnormal_immune_system | 2.93764159 |
| 4 | MP0001800_abnormal_humoral_immune | 2.85924345 |
| 5 | MP0005387_immune_system_phenotype | 2.82451722 |
| 6 | MP0001790_abnormal_immune_system | 2.82451722 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.75855122 |
| 8 | MP0002419_abnormal_innate_immunity | 2.62021417 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.61944998 |
| 10 | MP0009785_altered_susceptibility_to | 2.61369330 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.60138512 |
| 12 | MP0005671_abnormal_response_to | 2.59838781 |
| 13 | MP0008057_abnormal_DNA_replication | 2.58100596 |
| 14 | MP0005025_abnormal_response_to | 2.46165560 |
| 15 | MP0003303_peritoneal_inflammation | 2.43066083 |
| 16 | MP0002723_abnormal_immune_serum | 2.41174307 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.22211918 |
| 18 | MP0001819_abnormal_immune_cell | 2.21452011 |
| 19 | MP0002254_reproductive_system_inflammat | 2.20351526 |
| 20 | MP0006082_CNS_inflammation | 2.19128804 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.18501097 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.08129632 |
| 23 | MP0001853_heart_inflammation | 2.05536443 |
| 24 | MP0003724_increased_susceptibility_to | 1.99956475 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.99533977 |
| 26 | * MP0005464_abnormal_platelet_physiology | 1.99299830 |
| 27 | MP0009840_abnormal_foam_cell | 1.91470774 |
| 28 | MP0004510_myositis | 1.88814116 |
| 29 | MP0002405_respiratory_system_inflammati | 1.85685511 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.85171427 |
| 31 | MP0004947_skin_inflammation | 1.83110478 |
| 32 | MP0002398_abnormal_bone_marrow | 1.80239578 |
| 33 | MP0000716_abnormal_immune_system | 1.78925248 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.76043447 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.71088732 |
| 36 | MP0005360_urolithiasis | 1.70117036 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.68645283 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.66426032 |
| 39 | MP0002006_tumorigenesis | 1.65944396 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.65621175 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.63127548 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.58490782 |
| 43 | MP0001873_stomach_inflammation | 1.55862451 |
| 44 | MP0008058_abnormal_DNA_repair | 1.54979793 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.54085706 |
| 46 | MP0008469_abnormal_protein_level | 1.51692979 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.51610105 |
| 48 | MP0002722_abnormal_immune_system | 1.51064687 |
| 49 | MP0002429_abnormal_blood_cell | 1.48947775 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.47699462 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.44839673 |
| 52 | MP0005310_abnormal_salivary_gland | 1.39379587 |
| 53 | MP0008004_abnormal_stomach_pH | 1.35705714 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.35650412 |
| 55 | MP0009764_decreased_sensitivity_to | 1.35648115 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.34624816 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.32735708 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.32735708 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.31926284 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.29023726 |
| 61 | MP0008007_abnormal_cellular_replicative | 1.24365877 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.22648792 |
| 63 | MP0009278_abnormal_bone_marrow | 1.21087653 |
| 64 | MP0000858_altered_metastatic_potential | 1.19034848 |
| 65 | MP0003111_abnormal_nucleus_morphology | 1.15073361 |
| 66 | MP0005365_abnormal_bile_salt | 1.14293316 |
| 67 | MP0003448_altered_tumor_morphology | 1.12418935 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.11045573 |
| 69 | MP0003252_abnormal_bile_duct | 1.10644360 |
| 70 | MP0000609_abnormal_liver_physiology | 1.10392295 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 1.08936379 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 1.08925364 |
| 73 | MP0009763_increased_sensitivity_to | 1.06823200 |
| 74 | MP0005451_abnormal_body_composition | 1.04728398 |
| 75 | MP0000343_altered_response_to | 1.03622519 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 1.00462377 |
| 77 | MP0010307_abnormal_tumor_latency | 0.99313162 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.99086469 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.96827174 |
| 80 | MP0003828_pulmonary_edema | 0.96489822 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.96414939 |
| 82 | MP0002933_joint_inflammation | 0.94882434 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.93743214 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.88783058 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.88297588 |
| 86 | MP0000604_amyloidosis | 0.87854728 |
| 87 | MP0003786_premature_aging | 0.87302103 |
| 88 | MP0003077_abnormal_cell_cycle | 0.86449308 |
| 89 | MP0000490_abnormal_crypts_of | 0.86294165 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.85861197 |
| 91 | MP0008995_early_reproductive_senescence | 0.85437061 |
| 92 | MP0003075_altered_response_to | 0.84752602 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84107716 |
| 94 | MP0001851_eye_inflammation | 0.82586191 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.82411853 |
| 96 | MP0002132_abnormal_respiratory_system | 0.81130758 |
| 97 | MP0004957_abnormal_blastocyst_morpholog | 0.80137444 |
| 98 | MP0003866_abnormal_defecation | 0.79779673 |
| 99 | MP0003045_fibrosis | 0.79296363 |
| 100 | MP0000249_abnormal_blood_vessel | 0.77889933 |
| 101 | MP0000313_abnormal_cell_death | 0.76853796 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.76684663 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.76615920 |
| 104 | MP0005166_decreased_susceptibility_to | 0.74217308 |
| 105 | MP0000598_abnormal_liver_morphology | 0.73038544 |
| 106 | MP0006036_abnormal_mitochondrial_physio | 0.73002148 |
| 107 | MP0005647_abnormal_sex_gland | 0.70803295 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.70777047 |
| 109 | MP0001764_abnormal_homeostasis | 0.70656749 |
| 110 | MP0000371_diluted_coat_color | 0.69697665 |
| 111 | MP0002009_preneoplasia | 0.68204315 |
| 112 | MP0008260_abnormal_autophagy | 0.67721669 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.67544140 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.67429880 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.66413252 |
| 116 | MP0009697_abnormal_copulation | 0.66391115 |
| 117 | MP0006054_spinal_hemorrhage | 0.65227216 |
| 118 | MP0005266_abnormal_metabolism | 0.63652523 |
| 119 | MP0005390_skeleton_phenotype | 0.62945345 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62575339 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.62204679 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.61825159 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.61537847 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.60658430 |
| 125 | MP0002928_abnormal_bile_duct | 0.60546862 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.60309276 |
| 127 | MP0003186_abnormal_redox_activity | 0.59567105 |
| 128 | MP0005165_increased_susceptibility_to | 0.59427421 |
| 129 | MP0001663_abnormal_digestive_system | 0.59242375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.99232079 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.90702833 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.52368718 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.82338598 |
| 5 | Recurrent skin infections (HP:0001581) | 4.13131965 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 4.09919663 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.06609224 |
| 8 | Recurrent viral infections (HP:0004429) | 3.89195373 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.74374682 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.68654519 |
| 11 | Agammaglobulinemia (HP:0004432) | 3.60755594 |
| 12 | Cellulitis (HP:0100658) | 3.60590881 |
| 13 | Colitis (HP:0002583) | 3.53472680 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.51983880 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.50804448 |
| 16 | Myositis (HP:0100614) | 3.49300368 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38358799 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38358799 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.30311763 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26818443 |
| 21 | Meningitis (HP:0001287) | 3.26025561 |
| 22 | Myocardial infarction (HP:0001658) | 3.20667392 |
| 23 | Inflammation of the large intestine (HP:0002037) | 3.10369331 |
| 24 | Vasculitis (HP:0002633) | 3.08965711 |
| 25 | Acute lymphatic leukemia (HP:0006721) | 3.07609713 |
| 26 | Periodontitis (HP:0000704) | 3.06455450 |
| 27 | Obstructive lung disease (HP:0006536) | 3.05606925 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05606925 |
| 29 | Gingivitis (HP:0000230) | 3.04746053 |
| 30 | Pustule (HP:0200039) | 2.98116219 |
| 31 | Osteomyelitis (HP:0002754) | 2.96070687 |
| 32 | Chronic otitis media (HP:0000389) | 2.95188730 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.92683202 |
| 34 | Orchitis (HP:0100796) | 2.90426496 |
| 35 | Gastrointestinal stroma tumor (HP:0100723) | 2.89909620 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.87922086 |
| 37 | Acute myeloid leukemia (HP:0004808) | 2.85687342 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84954271 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.82051276 |
| 40 | Increased IgM level (HP:0003496) | 2.81251755 |
| 41 | Amaurosis fugax (HP:0100576) | 2.79012111 |
| 42 | Joint hemorrhage (HP:0005261) | 2.78113866 |
| 43 | Stomach cancer (HP:0012126) | 2.77512706 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.76518660 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.74540610 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.74168417 |
| 47 | Optic neuritis (HP:0100653) | 2.74168417 |
| 48 | IgM deficiency (HP:0002850) | 2.73928928 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72315531 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72315531 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72315531 |
| 52 | Gingival bleeding (HP:0000225) | 2.69910351 |
| 53 | Recurrent pneumonia (HP:0006532) | 2.68801707 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.65215197 |
| 55 | Viral hepatitis (HP:0006562) | 2.64775909 |
| 56 | Fatigue (HP:0012378) | 2.64612672 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.61043690 |
| 58 | Thrombocytosis (HP:0001894) | 2.59234812 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.59225225 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58707803 |
| 61 | Glomerulonephritis (HP:0000099) | 2.56658459 |
| 62 | Arterial thrombosis (HP:0004420) | 2.51944810 |
| 63 | Urticaria (HP:0001025) | 2.47256763 |
| 64 | Axonal loss (HP:0003447) | 2.44451950 |
| 65 | Epistaxis (HP:0000421) | 2.43829571 |
| 66 | Eosinophilia (HP:0001880) | 2.42415910 |
| 67 | Hematochezia (HP:0002573) | 2.41614737 |
| 68 | Recurrent lower respiratory tract infections (HP:0002783) | 2.40076857 |
| 69 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.39112771 |
| 70 | Petechiae (HP:0000967) | 2.38983717 |
| 71 | Leukocytosis (HP:0001974) | 2.38877701 |
| 72 | Thyroiditis (HP:0100646) | 2.38856865 |
| 73 | Abnormality of T cell number (HP:0011839) | 2.37478596 |
| 74 | Impaired platelet aggregation (HP:0003540) | 2.34526358 |
| 75 | Abnormal platelet function (HP:0011869) | 2.34526358 |
| 76 | Lymphopenia (HP:0001888) | 2.33405864 |
| 77 | Complement deficiency (HP:0004431) | 2.33375865 |
| 78 | Prostate neoplasm (HP:0100787) | 2.30770146 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.30759649 |
| 80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.30046050 |
| 81 | Abnormality of complement system (HP:0005339) | 2.30002366 |
| 82 | Abnormality of T cell physiology (HP:0011840) | 2.29770725 |
| 83 | Encephalitis (HP:0002383) | 2.27057424 |
| 84 | Recurrent sinusitis (HP:0011108) | 2.27004861 |
| 85 | Stomatitis (HP:0010280) | 2.26730450 |
| 86 | Chest pain (HP:0100749) | 2.26711489 |
| 87 | Abnormality of T cells (HP:0002843) | 2.26204804 |
| 88 | T lymphocytopenia (HP:0005403) | 2.25514029 |
| 89 | Granulocytopenia (HP:0001913) | 2.20536007 |
| 90 | Chronic diarrhea (HP:0002028) | 2.20346261 |
| 91 | Purpura (HP:0000979) | 2.18659082 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.18182908 |
| 93 | Sepsis (HP:0100806) | 2.17491164 |
| 94 | Abnormality of male internal genitalia (HP:0000022) | 2.17457028 |
| 95 | Increased IgE level (HP:0003212) | 2.16089218 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13923520 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.13923520 |
| 98 | Acute hepatic failure (HP:0006554) | 2.13572576 |
| 99 | Tetraparesis (HP:0002273) | 2.13284790 |
| 100 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.12051662 |
| 101 | Papilloma (HP:0012740) | 2.11507128 |
| 102 | Keratoconjunctivitis (HP:0001096) | 2.10686976 |
| 103 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09858153 |
| 104 | Lymphoma (HP:0002665) | 2.08286740 |
| 105 | Disinhibition (HP:0000734) | 2.06273575 |
| 106 | Emphysema (HP:0002097) | 2.05821523 |
| 107 | Abnormality of eosinophils (HP:0001879) | 2.05590002 |
| 108 | Hemoptysis (HP:0002105) | 2.04909120 |
| 109 | IgG deficiency (HP:0004315) | 2.04553834 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03619671 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03619671 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03619671 |
| 113 | Thick nail (HP:0001805) | 2.03457382 |
| 114 | Skin ulcer (HP:0200042) | 2.03049527 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 2.02962948 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 2.00675993 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00675993 |
| 118 | Hypergammaglobulinemia (HP:0010702) | 1.99055275 |
| 119 | IgA deficiency (HP:0002720) | 1.98399248 |
| 120 | Skin rash (HP:0000988) | 1.95875332 |
| 121 | Abnormality of B cell number (HP:0010975) | 1.95288162 |
| 122 | B lymphocytopenia (HP:0010976) | 1.95288162 |
| 123 | Verrucae (HP:0200043) | 1.94967188 |
| 124 | Myelodysplasia (HP:0002863) | 1.93315027 |
| 125 | Neutropenia (HP:0001875) | 1.92033909 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92016604 |
| 127 | Abnormality of lateral ventricle (HP:0030047) | 1.91466822 |
| 128 | Basal cell carcinoma (HP:0002671) | 1.91100845 |
| 129 | Increased serum ferritin (HP:0003281) | 1.91087725 |
| 130 | Polygenic inheritance (HP:0010982) | 1.90890024 |
| 131 | Hepatosplenomegaly (HP:0001433) | 1.90598448 |
| 132 | Loss of speech (HP:0002371) | 1.88333804 |
| 133 | Albinism (HP:0001022) | 1.88117855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.82054506 |
| 2 | MAP3K14 | 3.50147382 |
| 3 | TYK2 | 2.96591902 |
| 4 | IRAK4 | 2.72112980 |
| 5 | TBK1 | 2.67553081 |
| 6 | KIT | 2.62417968 |
| 7 | BLK | 2.60634784 |
| 8 | IRAK3 | 2.55527533 |
| 9 | ERN1 | 2.31008846 |
| 10 | TAOK3 | 2.26307530 |
| 11 | RIPK4 | 2.23950128 |
| 12 | TGFBR2 | 2.15414276 |
| 13 | IKBKB | 2.05935794 |
| 14 | JAK1 | 2.00241614 |
| 15 | CSF1R | 1.98134410 |
| 16 | IKBKE | 1.97217810 |
| 17 | SYK | 1.90551463 |
| 18 | TXK | 1.90196316 |
| 19 | JAK3 | 1.87393869 |
| 20 | PRPF4B | 1.86130388 |
| 21 | STK10 | 1.85705337 |
| 22 | * BTK | 1.83670257 |
| 23 | BRSK2 | 1.79120913 |
| 24 | ZAP70 | 1.70326435 |
| 25 | PIM2 | 1.66784117 |
| 26 | FLT3 | 1.50886817 |
| 27 | GRK6 | 1.49215491 |
| 28 | NEK9 | 1.49121030 |
| 29 | MAP2K3 | 1.46747957 |
| 30 | * ITK | 1.46588595 |
| 31 | FRK | 1.46431499 |
| 32 | STK24 | 1.41024380 |
| 33 | SIK3 | 1.39989394 |
| 34 | CHUK | 1.38330717 |
| 35 | PIM1 | 1.36251029 |
| 36 | MST4 | 1.33642464 |
| 37 | MAP3K13 | 1.32974089 |
| 38 | LYN | 1.32681110 |
| 39 | FGFR4 | 1.31295998 |
| 40 | * TEC | 1.31013796 |
| 41 | LRRK2 | 1.28480771 |
| 42 | CSK | 1.24116117 |
| 43 | * HCK | 1.20023396 |
| 44 | LCK | 1.17328571 |
| 45 | MKNK1 | 1.15605873 |
| 46 | EPHB1 | 1.14003100 |
| 47 | MAP3K3 | 1.12068484 |
| 48 | PTK6 | 1.11200623 |
| 49 | CDK12 | 1.09148661 |
| 50 | CCNB1 | 1.06955382 |
| 51 | JAK2 | 1.06017770 |
| 52 | RPS6KA4 | 1.05631867 |
| 53 | NLK | 1.04655846 |
| 54 | MAP3K10 | 1.03490676 |
| 55 | TNK2 | 1.02840561 |
| 56 | RPS6KB2 | 0.94928173 |
| 57 | PLK4 | 0.93301905 |
| 58 | STK4 | 0.88529545 |
| 59 | PIK3CG | 0.86413152 |
| 60 | FES | 0.85596171 |
| 61 | FGFR3 | 0.85329463 |
| 62 | TGFBR1 | 0.82087328 |
| 63 | SIK2 | 0.81553081 |
| 64 | MATK | 0.81427554 |
| 65 | ACVR1B | 0.80861669 |
| 66 | CDK6 | 0.77223023 |
| 67 | NUAK1 | 0.76665072 |
| 68 | MARK3 | 0.75977423 |
| 69 | STK16 | 0.75319757 |
| 70 | PKN2 | 0.74746235 |
| 71 | DYRK1B | 0.73477382 |
| 72 | STK3 | 0.73452758 |
| 73 | NME2 | 0.73091088 |
| 74 | EPHA3 | 0.72929965 |
| 75 | MAPKAPK3 | 0.71391146 |
| 76 | SCYL2 | 0.70977979 |
| 77 | IRAK2 | 0.70009571 |
| 78 | PRKCQ | 0.69562478 |
| 79 | TAOK2 | 0.68732318 |
| 80 | TRPM7 | 0.68590648 |
| 81 | TTN | 0.67083714 |
| 82 | MKNK2 | 0.64011529 |
| 83 | CAMK1D | 0.63752434 |
| 84 | EIF2AK3 | 0.61871393 |
| 85 | ERBB3 | 0.57464974 |
| 86 | ABL1 | 0.56815791 |
| 87 | GRK7 | 0.55109826 |
| 88 | CLK1 | 0.55090757 |
| 89 | MAP3K11 | 0.53675246 |
| 90 | MAPKAPK2 | 0.52842303 |
| 91 | PRKCD | 0.52132743 |
| 92 | CDK9 | 0.51826935 |
| 93 | EGFR | 0.51734573 |
| 94 | MAPK11 | 0.51675721 |
| 95 | ZAK | 0.50515873 |
| 96 | PRKAA2 | 0.49911034 |
| 97 | CDC7 | 0.49823508 |
| 98 | EEF2K | 0.48988492 |
| 99 | RAF1 | 0.47794724 |
| 100 | MAP3K1 | 0.47596702 |
| 101 | PBK | 0.47519847 |
| 102 | EIF2AK2 | 0.45623846 |
| 103 | EIF2AK1 | 0.45522291 |
| 104 | RPS6KA6 | 0.44851106 |
| 105 | MAP3K5 | 0.44465887 |
| 106 | BMPR2 | 0.42975629 |
| 107 | KDR | 0.42017467 |
| 108 | PDK1 | 0.41761008 |
| 109 | DAPK2 | 0.40161187 |
| 110 | SIK1 | 0.38406872 |
| 111 | TRIB3 | 0.38031707 |
| 112 | RPS6KC1 | 0.36901482 |
| 113 | RPS6KL1 | 0.36901482 |
| 114 | FGR | 0.36890874 |
| 115 | MAPK3 | 0.36794796 |
| 116 | MAPK4 | 0.36358801 |
| 117 | MAPK7 | 0.36112420 |
| 118 | CDK4 | 0.35571064 |
| 119 | MAPKAPK5 | 0.33992430 |
| 120 | ATR | 0.33560031 |
| 121 | BRD4 | 0.32480144 |
| 122 | MAPK15 | 0.31043558 |
| 123 | MAP2K2 | 0.30249285 |
| 124 | CHEK2 | 0.29694855 |
| 125 | INSRR | 0.29199771 |
| 126 | HIPK2 | 0.29076055 |
| 127 | BMPR1B | 0.28315989 |
| 128 | MAP3K7 | 0.27633988 |
| 129 | IRAK1 | 0.27456636 |
| 130 | MAP3K8 | 0.27326447 |
| 131 | * IGF1R | 0.25997423 |
| 132 | YES1 | 0.25948146 |
| 133 | MAPK12 | 0.25610941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02132222 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.89507967 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86158231 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.68423368 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.61136153 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.45709143 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31713445 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.14189062 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.02911754 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.95017411 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90561405 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89383086 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.79184265 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78931284 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78468322 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.76678310 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.76486940 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75131624 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74014566 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71348539 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.71123037 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66534863 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.58191064 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54874710 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53498179 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50341766 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.48358992 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45021488 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44743364 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.43252455 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.42955993 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.39553025 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38987378 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37833852 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.33884972 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.30461501 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19974328 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18816275 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18743542 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16734744 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.08285123 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05793195 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03406261 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.01004132 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.00973163 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 0.97142076 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96262590 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95964788 |
| 49 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95587407 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94621124 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.92589589 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90525670 |
| 53 | DNA replication_Homo sapiens_hsa03030 | 0.90476849 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90362341 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.90013428 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89054914 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.87494389 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.85988964 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84336543 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84290043 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83609368 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.83469747 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82658622 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81776361 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80971467 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79146263 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77804841 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75487917 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71599231 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.71126397 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70137407 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68039875 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67633684 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66718692 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65594396 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64252267 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62032219 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.61472132 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.60273315 |
| 80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60200043 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59648070 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57662687 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56604554 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56204674 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55930691 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54129221 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53982280 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51988016 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51429437 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51184252 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51122657 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49625040 |
| 93 | Spliceosome_Homo sapiens_hsa03040 | 0.49324855 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49292944 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48886781 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47445881 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46698749 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46494817 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46304258 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.46287931 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.45800682 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45726891 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45558658 |
| 104 | Proteasome_Homo sapiens_hsa03050 | 0.44708658 |
| 105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44293519 |
| 106 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43954949 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43641929 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43092189 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42279522 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.42244090 |
| 111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42136572 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41678746 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41518011 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40857955 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39920344 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39837038 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38926323 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.38439663 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37434552 |
| 120 | RNA transport_Homo sapiens_hsa03013 | 0.33670830 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31119002 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28710549 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.28034056 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26859627 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26313959 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24796179 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23669730 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23525355 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21742428 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21677783 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20600378 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.20156568 |
| 133 | Cell cycle_Homo sapiens_hsa04110 | 0.19231407 |
| 134 | Ribosome_Homo sapiens_hsa03010 | 0.18672188 |

